Alpha Centric Advisors LLC Insmed Inc Transaction History
Alpha Centric Advisors LLC
- $97.4 Million
- Q4 2024
A detailed history of Alpha Centric Advisors LLC transactions in Insmed Inc stock. As of the latest transaction made, Alpha Centric Advisors LLC holds 3,930 shares of INSM stock, worth $287,165. This represents 0.28% of its overall portfolio holdings.
Number of Shares
3,930
Previous 5,000
21.4%
Holding current value
$287,165
Previous $365,000
25.75%
% of portfolio
0.28%
Previous 0.31%
Shares
12 transactions
Others Institutions Holding INSM
# of Institutions
498Shares Held
189MCall Options Held
3.21MPut Options Held
2.72M-
Vanguard Group Inc Valley Forge, PA18.2MShares$1.33 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$1.04 Billion0.02% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y913MShares$947 Million84.75% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.7MShares$928 Million0.1% of portfolio
-
Capital International Investors Los Angeles, CA7.12MShares$520 Million0.1% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $9.9B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...